Pharmafile Logo

Digital technologies: Pharma’s answer to achieving net zero emissions?

As I wrote about earlier this year, it is clear that the climate crisis is no longer something for future generations to worry about, it’s already here and requires our urgent and undivided attention. The Pacific Northwest battled unprecedented “heat domes” in June, with temperatures getting close to 50°C (~120°F) in some places; other parts of western US and Canada remained covered in various degrees of ash and smoke for most of July and August. Likewise, Europethe Arctic, and many other places in the Northern Hemisphere also experienced record heatwaves and wildfires.

There is a lot of talk among companies about reaching “net zero” emissions by 2050. However, if this summer has taught us nothing else, it’s that that goal needs to be moved to 2030 or earlier if we want to limit the damage already done and ultimately save billions of dollars in healthcare and infrastructure costs.

What can Pharma do?

For Pharma and life science companies aiming to reach net zero, there are a few different paths to take…

To read our take on this topic, access the full article here!

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Increased Timeliness to Insight-gathering and Output Delivery in Virtual Advisory Boards

We've broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #3. Increased Timeliness to Insight-gathering and Output Delivery Based on...

Top 10 benefits of virtual advisory boards: Increased Engagement and Insights

#2. Increased Advisor Engagement and Quality and Quantity of Insights

Top 10 benefits of virtual advisory boards: Save Time and Resources

We've broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #1. Countless Hours of Time-savings and Substantially Reduced Costs We’ll...

10 Important Advisor Questions: Placement of Your Product in the Current/Future Treatment Algorithm

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

Top 10 Most Important Advisor Questions: Strengths and Weaknesses of Your Product

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

Top 10 Most Important Advisor Questions: Messaging and Branding

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

Top 10 Most Important Advisor Questions: Key Brand Attributes

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's the first one to keep...

Top 10 Most Important Advisor Questions: Unmet Needs

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's the first one to keep...

Amplifying Opinions of Patients & Caregivers for Higher Quality of Care

Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey...

Expanding Opportunities for Healthcare with “Digital Twins”

Brad Womble, Senior Director of Strategy, Marketing and Mergers & Acquisitions, at Jabil Healthcare dives into several thought-provoking topics, including how insights from “digital twins” can be used to improve...